Pliant Therapeutics, Inc. · NASDAQ:PLRX
ADAR1 Capital Management, LLC reported a 8.90% stake in Pliant Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
ADAR1 Capital Management, LLC reported a 8.90% stake in Pliant Therapeutics, Inc., 5,509,724 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 8.90%
- Shares
- 5,509,724
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ADAR1 Capital Management, LLC | 8.90% | 5,509,724 |
| Daniel Schneeberger | 8.90% | 5,509,724 |
Source
Related
- Pliant Therapeutics, Inc.
- ADAR1 Capital Management, LLC
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026
- Schedule 13G · Citadel Advisors LLC · Jan 30, 2026